扰乱昼夜节律和阿片类药物间接的不良影响:双向关系和假定的机制
Nasrin Mehranfard1, Maedeh Ghasemi2, Ehsan Saboory3
1Nanokadeh Darooee Samen Private Joint Stock Company, Urmia, Iran.
Journal of neuroendocrinology
|July 6, 2025
概括
扰乱昼夜节律会使慢性阿片类药物副作用恶化. 了解这种联系对于更好的长期阿片类药物治疗管理和患者的治疗结果至关重要.
科学领域:
- 时间生物学 时间生物学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 最近的研究表明,昼夜节律中断与慢性阿片类药物诱导的不良影响之间存在联系.
- 研究表明,身体的内部时钟 (心律系统) 和阿片类药物的作用之间存在着显著的双向关系.
- 如果不加以解决,这些相互作用可能会对长期阿片类药物治疗的有效性产生负面影响.
研究的目的:
- 审查昼夜节律与阿片类药物诱导的过敏症,依赖和戒断之间的关联.
- 探索潜在的潜在机制,包括神经递质系统,氧化还原状态和压力.
- 突出与其他生物节奏的相互作用,如睡眠-清醒周期和荷尔蒙波动.
主要方法:
- 关于动物和人类研究的文献综述.
- 对昼夜和阿片类系统之间的双向相互作用的分析.
- 探索神经生物学和生理学的途径.
主要成果:
- 循环节律障碍可能会加剧阿片类药物介导的不良影响.
- 阿片类药物可以扰乱正常的昼夜节律.
- 神经递质系统 (多巴胺基,血清胺基,诺拉德仁基),氧化还原状态和压力都与此有关.
- 与睡眠和清醒,黑激素和葡萄皮质激素节律的相互作用是显著的.
结论:
- 了解昼夜节律和阿片类药物效应之间的相互作用对于管理不良结果至关重要.
- 这些知识可能会导致改善长期阿片类药物使用的治疗策略.
- 对这些机制的进一步研究可以优化患者护理和治疗疗效.
相关概念视频
02:19Circadian Rhythms and Gene Regulation
4.2K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.2K
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
133
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
133
01:19Management of Insomnia
327
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
327
01:25Analgesia and Pain Management
816
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
816
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
247
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
247
01:22Opioid Receptors: Overview
1.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K